Literature DB >> 8816378

CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L.

S Shinde1, Y Wu, Y Guo, Q Niu, J Xu, I S Grewal, R Flavell, Y Liu.   

Abstract

The CD40 ligand (CD40L):CD40 interaction plays an important role in the activation of both T and B cells. However, the mechanisms by which this interaction is involved in activation of T cells is still unclear. Here we show that CD40L is not essential for T cell response to TCR engagement if the APC have costimulatory activity, although it is essential for T cell-mediated induction of such costimulatory activity. To determine the molecular basis of this activity, we have produced three mAbs that appear to recognize the costimulatory molecules rapidly induced by CD40L. Two of them recognize CD44H, which we showed to have CD28-independent costimulatory activity for T cells. The molecule recognized by the remaining mAb is hereby identified as ICAM-1. Furthermore, ICAM-1-mediated costimulation is likely to serve for a function similar to that mediated by the B7:CD28 interaction, as targeted mutation of CD28 renders T cell responses to Con A more dependent on ICAM-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816378

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Immune mechanisms of childhood asthma.

Authors:  C E Donovan; P W Finn
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes.

Authors:  Y Liu; R H Wenger; M Zhao; P J Nielsen
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

3.  Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation.

Authors:  Kiichi Kajino; Ichiro Nakamura; Hiromichi Bamba; Toshihiro Sawai; Kazumasa Ogasawara
Journal:  Immunology       Date:  2006-10-11       Impact factor: 7.397

4.  Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S M Cruickshank; J Southgate; J I Wyatt; P J Selby; L K Trejdosiewicz
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

5.  Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway.

Authors:  A O Tzianabos; A Chandraker; W Kalka-Moll; F Stingele; V M Dong; R W Finberg; R Peach; M H Sayegh
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

7.  CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge.

Authors:  S Gurunathan; K R Irvine; C Y Wu; J I Cohen; E Thomas; C Prussin; N P Restifo; R A Seder
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

8.  Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells.

Authors:  Kimberly A Shafer-Weaver; Stephanie K Watkins; Michael J Anderson; Lauren J Draper; Anatoli Malyguine; W Gregory Alvord; Norman M Greenberg; Arthur A Hurwitz
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

9.  CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection.

Authors:  P Borrow; D F Tough; D Eto; A Tishon; I S Grewal; J Sprent; R A Flavell; M B Oldstone
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  The transmembrane form of TNF-alpha drives autoantibody production in the absence of CD154: studies using MRL/Mp-Fas(lpr) mice.

Authors:  T Fujii; M Okada; T Mimori; J Craft
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.